AVTR (Avantor) EBIT per Share : $1.55 (TTM As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Avantor EBIT per Share?

Avantor's EBIT per Share for the three months ended in Mar. 2025 was $0.19. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 was $1.55.

During the past 12 months, the average EBIT per Share Growth Rate of Avantor was -17.70% per year. During the past 3 years, the average EBIT per Share Growth Rate was -16.70% per year. During the past 5 years, the average EBIT per Share Growth Rate was -4.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Avantor's EBIT per Share or its related term are showing as below:

AVTR' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -16.7 Med: 6.6 Max: 309.7
Current: -16.7

During the past 9 years, the highest 3-Year average EBIT per Share Growth Rate of Avantor was 309.70% per year. The lowest was -16.70% per year. And the median was 6.60% per year.

AVTR's 3-Year EBIT Growth Rate is ranked worse than
75.91% of 714 companies
in the Medical Devices & Instruments industry
Industry Median: 7.6 vs AVTR: -16.70

Avantor's EBIT for the three months ended in Mar. 2025 was $128 Mil.

Avantor EBIT per Share Historical Data

The historical data trend for Avantor's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avantor EBIT per Share Chart

Avantor Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

0.63

1.62

1.64

1.03

1.57

Avantor Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EBIT per Share	Get a 7-Day Free Trial															0.21	0.26	0.18	0.92	0.19

Avantor EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Avantor's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	1072.7	/	681.900
=	1.57

Avantor's EBIT per Share for the quarter that ended in Mar. 2025 is calculated as

	EBIT per Share		(Q: Mar. 2025 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	127.9	/	682.400
=	0.19

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.55

Avantor (NYSE:AVTR) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Avantor EBIT per Share Related Terms

Thank you for viewing the detailed overview of Avantor's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Avantor Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Avantor Inc (NYSE:AVTR) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

AVG:Germany AVTR:Austria

Address

100 Matsonford Road, Suite 200, Building One, Radnor Corporate Center, Radnor, PA, USA, 19087

Website

https://www.avantorsciences.com

Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.

Executives

Gregory L Summe	director	C/O GLEN CAPITAL PARTNERS LLC, 800 SOUTH STREET, SUITE 160, WALTHAM MA 02453
Joseph R Massaro	director	5725 DELPHI DRIVE, TROY MI 48098
Jonathan M Peacock	director	ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799
Lan Kang	director	100 MATSONFORD ROAD, RADNOR PA 19087
James Bramwell	officer: EVP, Strategic Partners	C/O AVANTOR, INC., 100 MATSONFORD ROAD, RADNOR PA 19087
Steven W Eck	officer: SVP & Chief Accounting Officer	C/O CSS INDUSTRIES, INC., 450 PLYMOUTH ROAD, SUITE 300, PLYMOUTH MEETING PA 19462
Christophe Couturier	officer: See Remarks	9 FOURTH AVENUE, C/O OVASCIENCE INC., CAMBRIDGE MA 02451
Benoit Gourdier	officer: EVP, Biopharma Production	100 MATSONFORD ROAD, RADNOR PA 19087
Frederic Vanderhaegen	officer: EVP, Europe	C/O AVANTOR, INC., 100 MATSONFORD ROAD, RADNOR PA 19087
Brittany Hankamer	officer: EVP, Chief HR Officer	100 MATSONFORD ROAD, RADNOR PA 19087
R. Brent Jones	officer: EVP, Chief Financial Officer	C/O PALL CORPORATION, 25 HARBOR PARK DRIVE, PORT WASHINGTON NY 11050
Claudius Sokenu	officer: EVP, Chief Legal & Compliance	C/O UNISYS CORPORATION, 801 LAKEVIEW DRIVE, BLUE BELL PA 19422
Randy Lee Stone	officer: EVP, Proprietary Products	974 CENTRE ROAD, CRP 730, WILMINGTON DE 19805
Gerard Brophy	officer: EVP, Biopharma Production	C/O AVANTOR, INC., 100 MATSONFORD ROAD, RADNOR PA 19087
Kitty Sahin	officer: EVP, Strategy&Corp Development	100 MATSONFORD ROAD, RADNOR PA 19087